{"id":4842,"date":"2023-08-14T10:31:10","date_gmt":"2023-08-14T14:31:10","guid":{"rendered":"https:\/\/neoaptamers.com\/?p=4842"},"modified":"2026-04-13T14:48:06","modified_gmt":"2026-04-13T18:48:06","slug":"innovating-the-landscape-of-aptamer-intellectual-property","status":"publish","type":"post","link":"https:\/\/neoaptamers.com\/fr\/innovating-the-landscape-of-aptamer-intellectual-property\/","title":{"rendered":"Innovating the Landscape of Aptamer Intellectual Property"},"content":{"rendered":"<p>Les aptam\u00e8res, des mol\u00e9cules d'acides nucl\u00e9iques polyvalentes dot\u00e9es d'un \u00e9norme potentiel pour les th\u00e9rapies cibl\u00e9es et les diagnostics, ont suscit\u00e9 une attention consid\u00e9rable ces derni\u00e8res ann\u00e9es. Nous sommes parmi les acteurs cl\u00e9s de ce domaine passionnant, reconnus pour notre leadership dans le domaine des brevets d'aptam\u00e8res. Avec des employ\u00e9s nomm\u00e9s sur 85 demandes de brevet publi\u00e9es bas\u00e9es sur 19 documents de priorit\u00e9 individuels, nous sommes \u00e0 la pointe de l'innovation en mati\u00e8re d'aptam\u00e8res. Nous travaillons avec nos clients pour comprendre et surmonter les contraintes en constante \u00e9volution de la propri\u00e9t\u00e9 intellectuelle des aptam\u00e8res. Dans ce blog, nous nous plongeons dans le travail r\u00e9volutionnaire de We, explorant leur approche unique de la propri\u00e9t\u00e9 intellectuelle des aptam\u00e8res et l'\u00e9volution du paysage de la protection par brevet.<\/p>\n<p><strong>D\u00e9fis de la propri\u00e9t\u00e9 intellectuelle des aptam\u00e8res:<\/strong> Les aptam\u00e8res portent la promesse de r\u00e9volutionner la m\u00e9decine, mais l'\u00e9volution du paysage de la propri\u00e9t\u00e9 intellectuelle des aptam\u00e8res pr\u00e9sente \u00e0 la fois des opportunit\u00e9s et des d\u00e9fis. Nous reconnaissons qu'il est crucial de naviguer dans le monde complexe des brevets pour exploiter pleinement le potentiel des aptam\u00e8res. Bien que nous ne soyons pas des avocats en brevets, nous collaborons avec l'un des meilleurs cabinets au monde pour la r\u00e9daction de brevets d'aptam\u00e8res, ICOSA, bas\u00e9 \u00e0 Paris, en France (https:\/\/www.icosa-europe.com\/).<\/p>\n<p><strong>\u00c9largissement de la couverture:<\/strong> Nous sommes des pionniers dans l'\u00e9largissement de la port\u00e9e des brevets d'aptam\u00e8res. Au lieu de se concentrer uniquement sur des s\u00e9quences sp\u00e9cifiques, nous incluons \u00e9galement des \u00e9l\u00e9ments structurels dans nos revendications. Cette approche strat\u00e9gique d\u00e9coule d'une m\u00e9tanalyse m\u00e9ticuleuse des structures au sein des biblioth\u00e8ques d'aptam\u00e8res s\u00e9lectionn\u00e9es. La reconnaissance que la capacit\u00e9 d'un aptam\u00e8re \u00e0 se lier \u00e0 une cible est \u00e9troitement li\u00e9e \u00e0 sa structure a ouvert la voie \u00e0 des revendications innovantes.<\/p>\n<p><strong>\u00c9l\u00e9ments structurels comme d\u00e9nominateurs communs:<\/strong> Le concept sous-tendant cette approche est fascinant. Les aptam\u00e8res avec des s\u00e9quences diverses mais partageant des \u00e9l\u00e9ments structurels communs pr\u00e9sentent des propri\u00e9t\u00e9s similaires. Cette compr\u00e9hension nous a conduit \u00e0 \u00e9tendre les revendications sur l'invention de groupes d'aptam\u00e8res remplissant des fonctions sp\u00e9cifiques pour inclure les \u00e9l\u00e9ments structurels partag\u00e9s entre ces aptam\u00e8res. Cette approche innovante offre non seulement une port\u00e9e plus large de protection, mais met \u00e9galement en \u00e9vidence l'importance des motifs structurels dans la fonction des aptam\u00e8res.<\/p>\n<p><strong>Interpr\u00e9tations globales et \u00e9volution:<\/strong> Il est important de noter que l'interpr\u00e9tation de la propri\u00e9t\u00e9 intellectuelle des aptam\u00e8res varie selon les r\u00e9gions g\u00e9ographiques. En tant que domaine en \u00e9volution, les approches des diff\u00e9rents offices de brevets et des tribunaux peuvent diff\u00e9rer. Dans le monde Neo, la r\u00e9alisation est claire : la valeur de vos innovations en mati\u00e8re d'aptam\u00e8res est \u00e9troitement li\u00e9e \u00e0 votre capacit\u00e9 \u00e0 les prot\u00e9ger par des revendications solides en mati\u00e8re de propri\u00e9t\u00e9 intellectuelle.<\/p>\n<p><strong>nnovation au-del\u00e0 de la science:<\/strong> Nous ne repoussons pas seulement les limites de la science des aptam\u00e8res, mais nous appliquons \u00e9galement l'innovation au domaine de la protection de la propri\u00e9t\u00e9 intellectuelle. Cette approche globale garantit que les avanc\u00e9es dans le d\u00e9veloppement des aptam\u00e8res sont prot\u00e9g\u00e9es, favorisant ainsi un environnement propice \u00e0 de nouvelles avanc\u00e9es.<\/p>\n<p>Dans le paysage dynamique de la recherche sur les aptam\u00e8res, nous nous d\u00e9marquons en tant que leaders en mati\u00e8re de brevets, relevant le d\u00e9fi de prot\u00e9ger des innovations r\u00e9volutionnaires. Notre collaboration avec ICOSA, notre approche pionni\u00e8re des \u00e9l\u00e9ments structurels dans les brevets et notre compr\u00e9hension des interpr\u00e9tations mondiales de la propri\u00e9t\u00e9 intellectuelle font de nous des acteurs essentiels dans le parcours visant \u00e0 exploiter pleinement le potentiel des aptam\u00e8res. \u00c0 mesure que ce domaine continue d'\u00e9voluer, nous veillons \u00e0 ce que ces mol\u00e9cules remarquables fa\u00e7onnent l'avenir de la m\u00e9decine.<\/p>","protected":false},"excerpt":{"rendered":"<p>Aptamers, versatile nucleic acid molecules with tremendous potential for targeted therapies and diagnostics, have gained significant attention in recent years. We are among the key players in this exciting field, known for our leadership in aptamer patenting. With employees named on 85 published patent applications based on 19 individual priority documents, we are at the&hellip;&nbsp;<a href=\"https:\/\/neoaptamers.com\/fr\/innovating-the-landscape-of-aptamer-intellectual-property\/\" rel=\"bookmark\">Lire la suite &raquo;<span class=\"screen-reader-text\">Innovating the Landscape of Aptamer Intellectual Property<\/span><\/a><\/p>","protected":false},"author":2,"featured_media":4844,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"off","neve_meta_content_width":70,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","footnotes":""},"categories":[8,11],"tags":[],"class_list":["post-4842","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-aptamers","category-aptamers-in-diagnostics"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Innovating the Landscape of Aptamer Intellectual Property<\/title>\n<meta name=\"description\" content=\"Explore the innovative world of aptamers as we discuss our unique approach to intellectual property and the evolving landscape of patent protection.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/neoaptamers.com\/fr\/innovating-the-landscape-of-aptamer-intellectual-property\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Innovating the Landscape of Aptamer Intellectual Property\" \/>\n<meta property=\"og:description\" content=\"Explore the innovative world of aptamers as we discuss our unique approach to intellectual property and the evolving landscape of patent protection.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/neoaptamers.com\/fr\/innovating-the-landscape-of-aptamer-intellectual-property\/\" \/>\n<meta property=\"og:site_name\" content=\"neoaptamers\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-14T14:31:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-13T18:48:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/08\/Blog-images.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Gregory Penner\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Gregory Penner\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/innovating-the-landscape-of-aptamer-intellectual-property\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/innovating-the-landscape-of-aptamer-intellectual-property\\\/\"},\"author\":{\"name\":\"Gregory Penner\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/person\\\/641d6a3e016e13414b8d0d0ffd5847ad\"},\"headline\":\"Innovating the Landscape of Aptamer Intellectual Property\",\"datePublished\":\"2023-08-14T14:31:10+00:00\",\"dateModified\":\"2026-04-13T18:48:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/innovating-the-landscape-of-aptamer-intellectual-property\\\/\"},\"wordCount\":495,\"publisher\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/innovating-the-landscape-of-aptamer-intellectual-property\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/Blog-images.png\",\"articleSection\":[\"Aptamers\",\"Aptamers in Diagnostics\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/innovating-the-landscape-of-aptamer-intellectual-property\\\/\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/innovating-the-landscape-of-aptamer-intellectual-property\\\/\",\"name\":\"Innovating the Landscape of Aptamer Intellectual Property\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/innovating-the-landscape-of-aptamer-intellectual-property\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/innovating-the-landscape-of-aptamer-intellectual-property\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/Blog-images.png\",\"datePublished\":\"2023-08-14T14:31:10+00:00\",\"dateModified\":\"2026-04-13T18:48:06+00:00\",\"description\":\"Explore the innovative world of aptamers as we discuss our unique approach to intellectual property and the evolving landscape of patent protection.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/innovating-the-landscape-of-aptamer-intellectual-property\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/neoaptamers.com\\\/innovating-the-landscape-of-aptamer-intellectual-property\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/innovating-the-landscape-of-aptamer-intellectual-property\\\/#primaryimage\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/Blog-images.png\",\"contentUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/Blog-images.png\",\"width\":1000,\"height\":800,\"caption\":\"Dropper over test tubes ready to be viewed under a microscope\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/innovating-the-landscape-of-aptamer-intellectual-property\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/neoaptamers.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Innovating the Landscape of Aptamer Intellectual Property\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#website\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/\",\"name\":\"Neoaptamers.com\",\"description\":\"Neoventures Biotechnology Inc.\",\"publisher\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/neoaptamers.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#organization\",\"name\":\"NeoVentures Biotechnology Inc.\",\"alternateName\":\"NVB\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png\",\"contentUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png\",\"width\":500,\"height\":500,\"caption\":\"NeoVentures Biotechnology Inc.\"},\"image\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/neoventures-biotechnology-inc-\\\/\",\"https:\\\/\\\/www.reddit.com\\\/user\\\/NeoVenturesBiotech\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@neoaptamers7964\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/person\\\/641d6a3e016e13414b8d0d0ffd5847ad\",\"name\":\"Gregory Penner\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g\",\"caption\":\"Gregory Penner\"},\"description\":\"Dr. Gregory Penner academic training was a blend of very practical plant breeding theory combined with molecular biology. He has used this blend of biology and mathematics to first develop and lead a cereal biotechnology research team with the government of Canada and subsequently as a global research leader with Monsanto Inc. He has been a thought leader in aptamer development globally for the last twenty years as CEO and President of NeoVentures. \u00a0He has led this company to financial stability without outside investment with an integrated approach to aptamer discovery and commercialization. In 2015, he co- founded a second company, NeoNeuro in Paris France, focused on an innovative approach to identify Aptamarkers for complex diseases. Connect with Dr. Penner on LinkedIn or for company updates, follow NeoVentures. Click here to get in touch with our team.\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Innovating the Landscape of Aptamer Intellectual Property","description":"Explore the innovative world of aptamers as we discuss our unique approach to intellectual property and the evolving landscape of patent protection.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/neoaptamers.com\/fr\/innovating-the-landscape-of-aptamer-intellectual-property\/","og_locale":"fr_FR","og_type":"article","og_title":"Innovating the Landscape of Aptamer Intellectual Property","og_description":"Explore the innovative world of aptamers as we discuss our unique approach to intellectual property and the evolving landscape of patent protection.","og_url":"https:\/\/neoaptamers.com\/fr\/innovating-the-landscape-of-aptamer-intellectual-property\/","og_site_name":"neoaptamers","article_published_time":"2023-08-14T14:31:10+00:00","article_modified_time":"2026-04-13T18:48:06+00:00","og_image":[{"width":1000,"height":800,"url":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/08\/Blog-images.png","type":"image\/png"}],"author":"Gregory Penner","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Gregory Penner","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/neoaptamers.com\/innovating-the-landscape-of-aptamer-intellectual-property\/#article","isPartOf":{"@id":"https:\/\/neoaptamers.com\/innovating-the-landscape-of-aptamer-intellectual-property\/"},"author":{"name":"Gregory Penner","@id":"https:\/\/neoaptamers.com\/#\/schema\/person\/641d6a3e016e13414b8d0d0ffd5847ad"},"headline":"Innovating the Landscape of Aptamer Intellectual Property","datePublished":"2023-08-14T14:31:10+00:00","dateModified":"2026-04-13T18:48:06+00:00","mainEntityOfPage":{"@id":"https:\/\/neoaptamers.com\/innovating-the-landscape-of-aptamer-intellectual-property\/"},"wordCount":495,"publisher":{"@id":"https:\/\/neoaptamers.com\/#organization"},"image":{"@id":"https:\/\/neoaptamers.com\/innovating-the-landscape-of-aptamer-intellectual-property\/#primaryimage"},"thumbnailUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/08\/Blog-images.png","articleSection":["Aptamers","Aptamers in Diagnostics"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/neoaptamers.com\/innovating-the-landscape-of-aptamer-intellectual-property\/","url":"https:\/\/neoaptamers.com\/innovating-the-landscape-of-aptamer-intellectual-property\/","name":"Innovating the Landscape of Aptamer Intellectual Property","isPartOf":{"@id":"https:\/\/neoaptamers.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/neoaptamers.com\/innovating-the-landscape-of-aptamer-intellectual-property\/#primaryimage"},"image":{"@id":"https:\/\/neoaptamers.com\/innovating-the-landscape-of-aptamer-intellectual-property\/#primaryimage"},"thumbnailUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/08\/Blog-images.png","datePublished":"2023-08-14T14:31:10+00:00","dateModified":"2026-04-13T18:48:06+00:00","description":"Explore the innovative world of aptamers as we discuss our unique approach to intellectual property and the evolving landscape of patent protection.","breadcrumb":{"@id":"https:\/\/neoaptamers.com\/innovating-the-landscape-of-aptamer-intellectual-property\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/neoaptamers.com\/innovating-the-landscape-of-aptamer-intellectual-property\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/neoaptamers.com\/innovating-the-landscape-of-aptamer-intellectual-property\/#primaryimage","url":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/08\/Blog-images.png","contentUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/08\/Blog-images.png","width":1000,"height":800,"caption":"Dropper over test tubes ready to be viewed under a microscope"},{"@type":"BreadcrumbList","@id":"https:\/\/neoaptamers.com\/innovating-the-landscape-of-aptamer-intellectual-property\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/neoaptamers.com\/"},{"@type":"ListItem","position":2,"name":"Innovating the Landscape of Aptamer Intellectual Property"}]},{"@type":"WebSite","@id":"https:\/\/neoaptamers.com\/#website","url":"https:\/\/neoaptamers.com\/","name":"Neoaptamers.com","description":"Neoventures Biotechnology Inc.","publisher":{"@id":"https:\/\/neoaptamers.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/neoaptamers.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/neoaptamers.com\/#organization","name":"NeoVentures Biotechnology Inc.","alternateName":"NVB","url":"https:\/\/neoaptamers.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/neoaptamers.com\/#\/schema\/logo\/image\/","url":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2024\/07\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png","contentUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2024\/07\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png","width":500,"height":500,"caption":"NeoVentures Biotechnology Inc."},"image":{"@id":"https:\/\/neoaptamers.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/neoventures-biotechnology-inc-\/","https:\/\/www.reddit.com\/user\/NeoVenturesBiotech\/","https:\/\/www.youtube.com\/@neoaptamers7964"]},{"@type":"Person","@id":"https:\/\/neoaptamers.com\/#\/schema\/person\/641d6a3e016e13414b8d0d0ffd5847ad","name":"Gregory Penner","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g","caption":"Gregory Penner"},"description":"Dr. Gregory Penner academic training was a blend of very practical plant breeding theory combined with molecular biology. He has used this blend of biology and mathematics to first develop and lead a cereal biotechnology research team with the government of Canada and subsequently as a global research leader with Monsanto Inc. He has been a thought leader in aptamer development globally for the last twenty years as CEO and President of NeoVentures. \u00a0He has led this company to financial stability without outside investment with an integrated approach to aptamer discovery and commercialization. In 2015, he co- founded a second company, NeoNeuro in Paris France, focused on an innovative approach to identify Aptamarkers for complex diseases. Connect with Dr. Penner on LinkedIn or for company updates, follow NeoVentures. Click here to get in touch with our team."}]}},"_links":{"self":[{"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/posts\/4842","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/comments?post=4842"}],"version-history":[{"count":4,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/posts\/4842\/revisions"}],"predecessor-version":[{"id":6507,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/posts\/4842\/revisions\/6507"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/media\/4844"}],"wp:attachment":[{"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/media?parent=4842"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/categories?post=4842"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/tags?post=4842"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}